A review of methods for computational prediction of blood-brain partitioning

Current Medicinal Chemistry - Central Nervous System Agents

Volumn 5, Issue 3, 2005, Pages 185-191

  Kaznessis, Yiannis N ^a  

^a University of Minnesota   (United States)

Author keywords

Blood brain partition coefficient; Computer simulations; QSAR

Indexed keywords

4 (2 DIPROPYLAMINOETHYL) 7 HYDROXY 2(3H) INDOLONE; FEXOFENADINE;

BLOOD BRAIN BARRIER; COMPUTER AIDED DESIGN; COMPUTER SIMULATION; DRUG DESIGN; DRUG PENETRATION; DRUG RESEARCH; DRUG STRUCTURE; ELECTRICITY; HIGH THROUGHPUT SCREENING; MOLECULAR INTERACTION; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

EID: 23844552172     PISSN: 15680150     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568015054863864     Document Type: Review

References (59)

1. De Vries, H. E.; Kuiper, J.; De Boer, A. G.; Van Berkel, T. J. C.; Breimer, D. D. The Blood-Brain Barrier in Neuroinflammatory Diseases. Pharmacol. Rev. 1997, 49, 143-155.
2. Pardridge, W.M. Blood-Brain Barrier Biology and Methodology. Neuravirol. 1999, 5, 556-69.
3. Tamai, I.; Tsuji, A. Drug Delivery Through the Blood-Brain Barrier. Adv. Drug Delivery Rev. 1996, 19, 401-424.
4. van de Waterbeemd, H. High-Throughput and In Silico Techniques in Drug Metabolism and Pharmacokinetics Curr. Opin. Drug Disc. & Develop. 2002, 5, 33-43.
5. Young, R. C.; Mitchell, R. C.; Brown, T. H.; Ganellin, C. R.; Griffiths, R.; Jones, M.; Rana, K. K.; Saunders, D.; Smith, I. R.; Sore, N. E.; Wilks, T. J. Development of a New Physicochemical Model for Brain Penetration and Application to the Design of Centrally Acting H2 Receptor Histamine Antagonists. J. Med. Chem. 1988, 31, 656-671.
6. Eddy, E. P.; Maleef, B. E.; Hart, T. K.; Smith, P. L. In Vitro Models to Predict Blood-Brain Barrier Permeability. Adv. Drug Deliv. Rev. 1997, 23, 185-198
7. Reichel, A.; Begley, D. J. Potential of Immobilized Artificial Membranes for Predicting Drug Penetration Across the Blood-Brain Barrier. Pharm. Res. 1998, 15, 1270-1274.
8. Feng, M.R. Assessment of Blood-Brain Barrier Penetration: In Silico, In Vitro and In Vivo. Curr. Drug Metab. 2002, 3, 647-57.
9. Lohmann, C.; Huwel, S.; Galla, H.J. Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. J. Drug Target 2002, 10, 263-76.
10. Hou, T.J.; Xu, X.J., ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors. J. Chem. Inf. Comput. Sci. 2003, 43, 2137-2152.
11. Clark, D.E., In Silico Prediction of Blood-Brain Barrier Permeation Drug Disc. Today 2003, 8, 927-933.
12. Terasaki, T.; Ohtsukia, S.; Horia, S.; Takanagaa, H.; Nakashimab E.; Hosoyac, K. New Approaches to in vitro Models of Blood-Brain Barrier Drug Transport. Drug Discov Today 2003, 8, 944-54.
13. Lundquist, S.; Renftel, M.; Brillault, J.; Fenart, L.; Cecchelli, R.; Dehouck, M.P. Prediction of Drug Transport Through the Blood-Brain Barrier In Vivo: a Comparison Between Two In Vitro Cell Models. Pharm. Res. 2002, 19, 976-81.
14. van Bree, J.B.; de Boer, A.G.; Danhof, M.; Ginsel, L.A.; Breimer, D.D. Characterization of an "In Vitro" Blood-Brain Barrier: Effects of Molecular Size and Lipophilicity on Cerebrovascular Endothelial Transport Rates of Drugs. J. Pharmacol. Exp. Ther. 1988, 247, 1233-9.
15. Gumbleton, M.; Audus, K.L. Progress and Limitations in the Use of In Vitro Cell Cultures to Serve as a Permeability Screen for the Blood-Brain Barrier. Jharm Sci. 2001, 90, 1681-98.
16. Franke, H.; Galla, H.J.; Beuckmann, C.T. An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res. 1999, 818, 65-71.
17. NIH website: http://pubchem.ncbi.nlm.nih.gov/
18. Abraham, M. H.; Chadha, H. S.; Mitchell, R. C. Hydrogen Bonding. 33. Factors that Influence the Distribution of Solutes Between Blood and Brain. J. Pharm. Sci. 1994, 83, 1257-1268
19. Abraham, M. H.; McGowan, J. C. The Use of Characteristic Volumes to Measure Cavity Terms in Reversed Phase Liquid Chromatography. Chromatographia 1987, 23, 243-246.
20. Abraham, M. H.; Chadha, H. S.; Mitchell, R. C. Hydrogen Bonding. Part 36. Determination of Blood Brain Distribution Using Octanol-Water Partition Coefficients. Drug Des. Discov. 1995, 13, 123-131
21. Norinder, U.; Sjoberg, P.; Osterberg, T. Theoretical Calculation and Prediction of Brain-Blood Partitioning of Organic Solutes Using MolSurf Parametrization and PLS Statistics. J. Pharm. Sci. 1998, 87, 952-959.
22. Sjoberg, P. MolSurf - a Generator of Chemical Descriptors for QSAR. In: 'Computer-Assisted Lead Finding and Optimization', Eds. Han van de Waterbeemd, Bernard Testa, Gerd Folkers, Verlag Helvetica Chimica Acta, CH - 4010 Basel, Switzerland, 1997, pp. 83-92.
23. Wold, S.; Johansson, E.; Cocchi, M. PLS - Partial Least Squares Projections to Latent Structures. In 3D QSAR in Drug Design; Kubinyi, H., Ed.; ESCOM: Leiden 1993, pp. 523-550.
24. Jolliffe, I. T. Principal Component Analysis in Chemistry; Springer-Verlag: New York, 1986.
25. Luco, J. M. Prediction of the Brain-Blood Distribution of a Large Set of Drugs from Structurally Derived Descriptors Using Partial Least-Squares (PLS) Modeling. J. Chem. Inf. Comput. Sci. 1999, 39, 396-404.
26. Cruciani, G.; Pastor, M.; Mannhold, R. Suitability of Molecular Descriptors for Database Mining. A Comparative Analysis. J. Med. Chem. 2002, 45, 2685-94
27. Cruciani, G.; Pastor, M.; Guba, W. VolSurf: a New Tool for the Pharmacokinetic Optimization of Lead Compounds. Eur. J. Pharm. Sci. 2000, Suppl 2, S29-39.
28. van de Waterbeemd, H.; Kansy, D. Hydrogen-Bonding Capacity and Brain Penetration. Chimia 1992, 46, 299-303.
29. Hutter, M.C. Prediction of blood-brain barrier permeation using quantum chemically derived information, J. Comp-Aid. Mol. Des. 2003, 17, 415-433.
30. Winkler, D.A.; Burden, F.R. Modelling Blood-Brain Barrier Partitioning Using Bayesian Neural Nets. J. Mol. Graph. & Mod. 2004, 22, 499-505.
31. Hou, T.J.; Xu, X.J. ADME Evaluation in Drug Discovery - 1. Applications of Genetic Algorithms to the Prediction of Blood-Brain Partitioning of a Large Set of Drugs. J. Mol. Mod. 2002, 8, 337-349.
32. Fu, X. C.; Wang, G. P.; Liang, W. Q.; Yu, Q. S Predicting blood-brain barrier penetration of drugs using an artificial neural network. Pharmazie 2004, 59(2), 126-130.
33. Teixidó, M.; Belda, I.; Rosello, X.; Gonzalez, S.; Fabre, M.; Llorá, X.; Bacardit, J.; Garrell, J.M.; Vilaró, S.; Albericio, F.; Giralt, E. Development of a Genetic Algorithm to Design and Identify Peptides that can Cross the Blood-Brain Barrier: 1. Design and validation in silico. QSAR & Combinatorial Science 2003, 22, 745-753.
34. Doninger, S.; Hofmann, T.; Yeh, J. Predicting CNS Permeability of Drug Molecules: Comparison of Neural Network and Support Vector Machine Algorithms J. Comp. Biol. 2002, 9, 849-864.
35. Bassolino-Klimas, D.; Alper, H. E.; Stouch, T. R. Solute Diffusion in Lipid Bilayer Membranes: an Atomic Level Study by Molecular Dynamics Simulation. Biochemistry 1993, 32, 12624-12637.
36. Jin, B.; Hopfinger, A. J. Characterization of Lipid Membrane Dynamics by Simulation: 3. Probing Molecular Transport Across the Phospholipid Bilayer. Pharm Res. 1996, 13, 1786-1794.
37. Iyer, M.; Mishra, R.; Han, Y.; Hopfinger, A. J. Predicting Blood-Brain Barrier Partitioning of Organic Molecules Using Membrane-Interaction QSAR Analysis Pharm. Res. 2002, 19, 1611-1621.
38. Jorgensen W.L; Duffy E. M. Prediction of Drug Solubility from Monte Carlo Simulations. Bioorg. Med. Chem. Lett., 2000, 10, 1155-4755.
39. Duffy, E. M.; Jorgensen, W. L. Prediction of Properties from Simulations: Free Energies of Solvation in Hexadecane, Octanol, and Water. J. Am. Chem. Soc. 2000, 122, 2878-2888.
40. Kaznessis, Y.N.; Snow, M.E.; Blankley, C.J. Prediction of Blood-Brain Partitioning Using Monte Carlo Simulations J. Comput. Aided Mol. Des. 2001, 15, 697-708
41. Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of Simple Potential Functions for Simulating Liquid Water. J. Chem. Phys. 1983, 79, 926-935.
42. Kaminski, G. A.; Jorgensen, W. L. A Quantum Mechanical and Molecular Mechanical Method Based on CMIA Charges: Applications to Solvent Effects on Organic Equilibria and Reactions. J. Phys. Chem. B. 1998, 102, 1787-1796.
43. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids, J. Amer. Chem. Soc. 1996, 118, 11225-11236.
44. Jorgensen, W. L.; Nguyen, T. B. Monte Carlo Simulations of the Hydration of Substituted Benzenes with OPLS Potential Functions J. of Comp. Chem. 1993, 14, 195-205.
45. Seiler, P. Interconversion of Lipophilicities from Hydrocarbon/Water systems into the Octanol/Water Systems. Eur. J. Med. Chem. 1974, 9, 473-479.
46. el Tayar, N.; Tsai, R. S.; Testa, B.; Carrupt, P. A.; Leo, A. Partitioning of Solutes in Different Solvent Systems: the Contribution of Hydrogen-Bonding Capacity and Polarity. J. Pharm. Sci. 1991, 80, 590-598.
47. Lombardo, F.; Blake, J. F.; Curatolo, W. J. Computation of Brain-Blood Partitioning of Organic Solutes via Free Energy Calculations. J. Med. Chem. 1996, 39, 4750-4755
48. Kaliszan, R.; Markuszewski, M. Brain/Blood Distribution Described by a Combination of Partition Coefficient and Molecular Mass. Int. J. Pharmaceutics 1996, 145, 9-16.
49. Feher, M.; Sourial, S.; Schmidt, J. M.; A Simple Model for the Prediction of Blood-Brain Partitioning. Int. J. Pharmaceutics 2000, 201, 239-247.
50. Clark, D.E. Rapid Calculation of Polar Molecular Surface Area and its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration. J. Pharm. Sci. 1999, 88, 815-21
51. Ecker, G.; Noe, C.R. In silico prediction models for blood-brain barrier permeation. Curr. Med Chem. 2004, 11, 1617-1628.
52. Terasaki, T.; Ohtsuki, S.; Hori, S.; Takanaga, H.; Nakashima, E.; Hosoya, K. New approaches to in vitro models of blood-brain barrier drug transport. Drug Discovery Today 2003, 8, 944-954.
53. Fu, X.-C.; Chen, C.-X.; Liang, W.-Q.; Yu, Q.-S. Predicting blood-brain barrier penetration of drugs by polar molecular surface area and molecular volume. Acta Pharmacologica Sinica 2001, 22, 663-668.
54. Sippl, W. Computational approaches for the prediction of blood-brain barrier permeation. Cur. Med. Chem. - Central Nervous System Agents, 2002, 2, 211-227.
55. Gratton, J.A.; Abraham, M.H.; Bradbury, M.W.; Chadha, H.S. Molecular factors influencing drug transfer across the blood-brain barrier. J. Pharmacy and Pharmacology 1997, 49, 1211-1216.
56. Kelder, J.; Grootenhuis, P. D.; Bayada, D. M.; Delbressine, L. P.; Ploemen, J. P.; Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs. Pharm. Res. 1999, 16, 1514-1519.
57. Fischer, H.; Gottschlich, R.; Seelig, A. Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion. J. Membr. Biol. 1998, 165, 201-211.
58. Seelig, A.; Gottschlich, R.; Devant, R. M. A Method to Determine the Ability of Drugs to Diffuse Through the Blood-Brain Barrier. Proc. Natl. Acad. Sci. USA. 1994, 91, 68-72.
59. van de Waterbeemd, H.; Gifford, E. ADMET in Silico Modelling: Towards Prediction Paradise? Nature Rev. Drug Discov.. 2003, 2, 192-204.